Reaction
Brain Cancer Metastatic reporting signals
As of the last recalculation, Brain Cancer Metastatic appears in 684 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is LAPATINIB (PRR 19.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lapatinib | 10 | 19.9 | 19.9 |
| Dabrafenib | 10 | 14.6 | 14.6 |
| Temozolomide | 9 | 13.2 | 13.2 |
| Trametinib | 10 | 12.8 | 12.8 |
| Osimertinib | 13 | 12.6 | 12.6 |
| Ranitidine Hydrochloride | 16 | 9.1 | 9.2 |